Literature DB >> 555115

Phenylbutazone toxicity in ponies.

D H Snow, J A Bogan, T A Douglas, H Thompson.   

Abstract

The oral administration of phenylbutazone at a dose rate of approximately 10 mg per kg per day for seven to 14 days resulted in the development of signs of toxicity in seven of eight ponies treated. Clinical signs included anorexia, depression and abdominal oedema. Blood biochemical determinations showed a decrease in total plasma protein and calcium concentrations with an increase in urea concentration. These changes were considered indicative of water retention. Three of the ponies died during treatment following the development of shock. Shock was considered to arise from the submucosal oedema of the large intestine observed on necropsy. Oral ulceration was also found in these animals. In two ponies intravenous administration of phenylbutazone (4.0 mg per kg) for seven days was studied. In one of these ponies a marked decrease in total plasma protein concentration occurred.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 555115     DOI: 10.1136/vr.105.2.26

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  4 in total

1.  Clinical and pathological effects of flunixin meglumine administration to neonatal foals.

Authors:  J B Carrick; M G Papich; D M Middleton; J M Naylor; H G Townsend
Journal:  Can J Vet Res       Date:  1989-04       Impact factor: 1.310

2.  The protective effects of sucralfate and ranitidine in foals experimentally intoxicated with phenylbutazone.

Authors:  R J Geor; L Petrie; M G Papich; C Rousseaux
Journal:  Can J Vet Res       Date:  1989-04       Impact factor: 1.310

3.  Evaluation of the brain, renal, and hepatic effects of flunixin meglumine, ketoprofen, and phenylbutazone administration in Iranian fat-tailed sheep.

Authors:  Ali Asghar Mozaffari; Amin Derakhshanfar
Journal:  Trop Anim Health Prod       Date:  2011-04-19       Impact factor: 1.559

4.  The isoelectric focusing properties of serum alkaline phosphatase in disease and following prednisolone and phenylbutazone administration in the horse.

Authors:  R S Ellison; R M Jacobs
Journal:  Can J Vet Res       Date:  1990-01       Impact factor: 1.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.